Pennsylvania 2021-2022 Regular Session Status: In Committee Bipartisan · 5 R · 2 D cosponsors

HB 321 — An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.

Last action — PN 0295 Referred to INSURANCE

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2021-2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

Action History

  1. PN 0295 Referred to INSURANCE

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 243 not signed on

Sponsors (1)

  • Puskaric

Co-sponsors (9)

Not signed on (243)

243 members have not signed on to this bill.

Show all 243 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 321?
HB 321 is sponsored by Puskaric, Boback, Hershey, Joe Ciresi (Democratic), James B. Struzzi (Republican), Dan Moul (Republican), Aaron Bernstine (Republican), Barbara Gleim (Republican), Kyle J. Mullins (Democratic), and Joe Hamm (Republican).
What is the current status of HB 321?
This bill died with 2021-2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 321?
Track HB 321 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 321

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 321

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →